Open AccessNaltrexone treatment in clomiphene resistant women with polycystic ovary syndrome
Author(s) -
Mohamed I. Ahmed,
Antoni J. Dulęba,
O. El Shahat,
Mohamed Ibrahim,
A.A. Salem
Publication year - 2008
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/den273
Subject(s) - naltrexone , polycystic ovary , medicine , luteinizing hormone , hyperandrogenism , endocrinology , anovulation , gynecology , insulin resistance , opioid , hormone , insulin , receptor
Endogenous opiates may affect various aspects of reproductive and metabolic function in patients with polycystic ovary syndrome (PCOS). This study evaluated long-term inhibition of the opioid system using naltrexone in clomiphene citrate (CC)-resistant women with PCOS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom